HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients.

Abstract
Systemic light-chain (AL) amyloidosis may be associated with acquired factor X (FX) deficiency and optimal management of this coagulopathy is unknown. We reviewed our experience with 60 patients with isolated FX deficiency (< or =50%) due to AL amyloidosis that underwent an invasive procedure between 1975 and 2007. They were classified as having severe (<10%; n = 6), moderate (10-25%; n = 15), or mild (26-50%; n = 39) FX deficiency. The patients underwent a total of 112 procedures, 19 (17%) of which were managed with periprocedural treatment with one or more hemostatic agents. There were complications in 14 (13%) procedures (bleeding = 12, thrombosis = 1, death = 1). Baseline FX level was not predictive of bleeding risk; the only association with postintervention bleeding was central venous catheter placement. However, bleeding complications were relatively infrequent, particularly in patients with mild or moderate FX deficiency undergoing nonvascular procedures. Activated recombinant factor VII might be considered in patients undergoing major surgical procedures, but further experience is needed. Optimal management of AL patients with FX deficiency undergoing invasive procedures remains to be determined.
AuthorsCarrie A Thompson, Robert Kyle, Morie Gertz, John Heit, Rajiv Pruthi, Animesh Pardanani
JournalAmerican journal of hematology (Am J Hematol) Vol. 85 Issue 3 Pg. 171-3 (Mar 2010) ISSN: 1096-8652 [Electronic] United States
PMID20052750 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright2009 Wiley-Liss, Inc.
Chemical References
  • Amyloid
  • amyloid protein AL
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Amyloid
  • Amyloidosis (complications)
  • Catheterization, Central Venous (adverse effects)
  • Factor X Deficiency (etiology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications (etiology)
  • Postoperative Hemorrhage (etiology, mortality)
  • Punctures (adverse effects)
  • Retrospective Studies
  • Risk
  • Thrombosis (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: